Fig. 3
Effect of EDHB supplementation on a hemoglobin (Hb), b hematocrit (Hct), and c erythropoietin (EPO) level. Experimental animals were administered with the optimal dose (75 mg/kg b.wt.) of EDHB for 3 days. Circulatory EPO was estimated by ELISA in plasma. Increased levels of Hb, Hct and EPO after EDHB supplementation even under normoxia indicates improved oxygen carrying capacity of blood. Values are mean ± SD (n = 8/group). C control, D drug, (C vs. D c p < 0.05, a p < 0.01)